Lilly's Billion-Dollar Deal With CureVac For 'Next Generation' Immunotherapies

 
• By John Davis
  
Keys
Do immunotherapies hold the key to cancer? • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business